MARTIN CZEJKA; ANDREAS KISS; EVA OSTERMANN; JOHANNES SCHUELLER; MANSOOR AHMED; NAJIA MANSOOR; TASNEEM AHMAD. Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab. Journal of Analytical Oncology, [S. l.], v. 2, n. 4, p.  218–225, 2013. DOI: 10.6000/1927-7229.2013.02.04.4. Disponível em: https://www.neoplasiaresearch.com/pms/index.php/jao/article/view/89. Acesso em: 14 may. 2025.